Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2007
10/24/2007EP1846107A1 Neuroprotective agents and methods of their use
10/24/2007EP1846036A1 Reducing drug dependence or addiction
10/24/2007EP1846011A1 Composition comprising the extract of crude drug complex having neuroprotective activity for preventing and treating stroke and neurodegenerative diseases
10/24/2007EP1845999A1 Use of a fatty acid composition containing dha for the production of a medical product or a food stuff for the treatment of amyloidos-rerelated diseases
10/24/2007EP1845998A2 A method for treating neurologic diseases
10/24/2007EP1845969A2 Compositions and methods relating to mitochondrial hyperpolarization in neurological disease
10/24/2007EP1845968A2 Composition comprising an nmda receptor antagonist and levodopa and use thereof for treating neurological disease
10/24/2007EP1845957A1 Method for producing a drug extract that contains hydroxystilbene
10/24/2007EP1845954A2 Orally disintegrating composition of olanzapine or donepezil
10/24/2007EP1658081B1 Immunosuppressive effects of pteridine derivatives
10/24/2007EP1606307B1 Estrieno[3,2-b]/[3,4-c]pyrrole derivatives useful as modulators of the estrogen receptors
10/24/2007EP1587788B9 2,7-substituted indoles and their use as 5-ht6 modulators
10/24/2007EP1575590B1 Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders
10/24/2007EP1534710B1 Pyrazolopyrimidines as cyclin dependent kinase inhibitors
10/24/2007EP1471899B1 Use of ambroxol in the treatment of chronic pain
10/24/2007EP1207860B1 Controlled release pellet formulation
10/24/2007EP1178983B1 Indole-type derivatives as inhibitors of p38 kinase
10/24/2007CN101061123A Thienopyridinone compounds and methods of treatment
10/24/2007CN101061118A Substituted bicyclic imidazo-3-ylamine compounds
10/24/2007CN101061115A 2-acylaminothiazole derivatives
10/24/2007CN101061107A Amorphous object of cinnamide compound
10/24/2007CN101061106A Potentiators of glutamate receptors
10/24/2007CN101061105A Potentiators of glutamate receptors
10/24/2007CN101061098A Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors
10/24/2007CN101061097A Novel gamma secretase inhibitors
10/24/2007CN101061094A Piperazine derivatives for alkyloxindoles
10/24/2007CN101060885A Treating depressive disorders with carbonic anhydrase activators
10/24/2007CN101060863A Modulation of neuroglia-derived BDNF in the treatment and prevention of pain
10/24/2007CN101060860A Drug combination comprising a selective serotonin reuptake inhibitor and a glucocorticoid receptor antagonist for the treatment of depression
10/24/2007CN101060847A Loxapine analogs and methods of use thereof
10/24/2007CN101060836A New use for cannabinoid
10/24/2007CN101058823A Method of preparing cytidine disodium triphosphate and application
10/24/2007CN101058608A Human anti-Abeta(1-32) amyloid antibody, purifying method and use thereof
10/24/2007CN101058564A Aryl alkyl carbamate derivatives production and use thereof in therapy
10/24/2007CN101058543A Process for producing amine derivatives
10/24/2007CN101057948A Traditional Chinese medicinal preparation with intelligence promoting and nourishing the heart to calm the mind function and its preparation method
10/24/2007CN101057893A Traditional Chinese medicine for treating osteoproliferation, rheumatoid and rheumatic arthritis and sciatica
10/24/2007CN101057889A Compound with mulberry as main material products and its preparation technology
10/24/2007CN101057887A Northern schisandra stems or stems skin extraction, its preparation method and application
10/24/2007CN101057881A Medicine for treating laryngopharyngitis and intractable headache
10/24/2007CN101057857A Composition for preventing and improving Parkinson disease and its preparation method
10/24/2007CN101057848A Nicergoline dry emulsion and its preparation method and application
10/24/2007CN101057830A Naloxone hydrochloride sublingual spraying drug delivery system or composition and its preparation method
10/24/2007CN101057826A Oryzanol injection with ethyl oleate as solvent and its preparation method
10/24/2007CN101057693A Double embryo beverage
10/24/2007CN101057678A Composition containing natural plant extraction or monomer
10/24/2007CN101057674A Composition for preventing and curing diabetes
10/24/2007CN101057626A Sichuan fritillary bulb mint plum and its producing method
10/24/2007CN101057616A Recuperating tea
10/24/2007CN100344648C Cyclosporine analogue mixtures and their use as immunomodulating agents
10/24/2007CN100344646C Oligonucleotide-containing pharmacological compositions and their use
10/24/2007CN100344632C 稠合的呋喃化合物 Fused furan compound
10/24/2007CN100344616C Compounds for the treatment of metabolic disorders
10/24/2007CN100344605C Preparation method of 3-fluoro-5-nitro trifluor toluene
10/24/2007CN100344317C Gastrodia tuber capsule and its preparation process
10/24/2007CN100344314C Xinnaoshu dripping pill for invigorating qi and nourishing yin and its preparing method
10/24/2007CN100344309C Refining method for Liuweidihuang compound preparation by membrane technology separation
10/24/2007CN100344292C Injection for treating facial tic
10/23/2007US7285687 Such as 2-(3-methylcyclohexyl)-5-(1,1'-dimethylheptyl)-resorcinol for treatment of pain, inflammation and autoimmune disease
10/23/2007US7285683 Bicyclic and tricyclic cannabinoids
10/23/2007US7285680 β-alanine derivatives and the use thereof
10/23/2007US7285666 Pyrazolo[1,5-a] pyridines and medicines containing the same
10/23/2007US7285664 Heterocyclic or benzenic derivatives of lipoic acid, their preparation and their use as medicaments
10/23/2007US7285662 Therapeutic heterocyclic compounds
10/23/2007US7285635 Reducing the antigenicity of a proteinaceous compound while maintaining the compound's biological activity
10/23/2007US7285574 Methods for treating neural cell swelling
10/23/2007US7285563 e.g. N-Benzyl-N'-isoquinolin-5-ylurea; treatment of pain and other conditions ameliorated by the modulation of the function of the vanilloid-1 receptor (VR1)
10/23/2007US7285561 Imidazo-substituted compounds as p38 kinase inhibitors
10/23/2007US7285560 E.g., N-[(S)-2-diphenylamino-1-(5-oxo-4,5-dihydro[1,3,4]oxadizol-2-yl)ethyl]-2-(2-methylaminopyrimidin-4-yl)-1H-indole-5-carboxamide; used for treating rheumatoid arthritis, osteoarthritis, asthma, cardiac infarction, Alzheimer's diseases, cancer diseases or atherosclerosis
10/23/2007US7285559 Imidazo-substituted pyrido[2,3-d]pyrimidinylamines; treating arthritis, Crohn's disease, Alzheimer's disease, irritable bowel syndrome, adult respiratory distress syndrome, and chronic obstructive pulmonary disease.
10/23/2007US7285556 Antiproliferative agents; hematologic, nervous system, autoimmune diseases; osteoporosis, viral infections
10/23/2007US7285550 Triazolotriazines and pyrazolotriazines and methods of making and using the same
10/23/2007US7285549 Sulfamides and their use as endothelin receptor antagonists
10/23/2007US7285548 Urea substituted benzothiazoles
10/23/2007US7285525 Suppression of immune response via inhibition of cathepsin S
10/23/2007US7285415 Differentiated cell population which generate glial cells for treating central nervous system traumas and disorders
10/23/2007US7285293 Isolating modulators of amyloid expression; obtain plant, extract proteins, incubate with chromatographic column, elute, recover preferential protein
10/18/2007WO2007118033A1 Treatment of psychiatric patients with sleep disturbances an/or excessive daytime sleepiness with paliperidone
10/18/2007WO2007117995A2 Kinase inhibitors
10/18/2007WO2007117438A2 Methods for the production of functional protein from dna having a nonsense mutation and the treatment of disorders associated therewith
10/18/2007WO2007117413A1 Sulfonyl-3-heterocyclylindazole derivatives as 5-hydroxytryptamine-6 ligands
10/18/2007WO2007117165A1 New pharmaceutical compounds
10/18/2007WO2007117022A1 Chewing composition comprising coenzyme q10
10/18/2007WO2007116987A1 Functional food and drug having learning function-improving effect and antidepressant effect
10/18/2007WO2007116916A1 Liquid drug preparation for oral administration
10/18/2007WO2007116901A1 Novel arylamide derivative
10/18/2007WO2007116458A1 Therapeutic agent for neurodegenerative disease
10/18/2007WO2007116374A1 Novel sulfonamide compounds
10/18/2007WO2007116228A1 Piperidine derivatives for treatment of alzheimer's disease
10/18/2007WO2007116136A1 Use of agomelatine for the production of medicaments for use in the treatment of generalized anxiety disorder
10/18/2007WO2007116076A1 Mazindol combination in the treatment of attention deficit/hyperactivity
10/18/2007WO2007116074A1 Trimetazidine for use in the treatment of fibromyalgia syndrome and related conditions
10/18/2007WO2007115997A2 Combination preparations from modafinil, ritalin and topiramat for use in cocaine dependency and/or for treating impulse control disorders
10/18/2007WO2007115975A2 USE OF kappa OPIOID RECEPTOR ANTAGONIST-CONTAINING COMPOSITIONS FOR THE TREATMENT OF DISSOCIATIVE DISORDERS
10/18/2007WO2007115966A1 Heterocyclic gaba alpha subtype selective receptor modulators
10/18/2007WO2007115808A1 Arginine prodrugs with high therapeutic activity
10/18/2007WO2007115713A1 Treatment of multiple sclerosis and/or rheumatoid arthritis
10/18/2007WO2007115372A1 A method of modulating beta-amyloid peptide production
10/18/2007WO2007100880A8 Cinnoline and quinazoline derivates as phosphodiesterase 10 inhibitors
10/18/2007WO2007099227A3 Use of the engrailed homeodomain protein as an anxiolytic
1 ... 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 ... 1833